|Assembly Actions - Lowercase
Senate Actions - UPPERCASE
|Jun 21, 2012||referred to health|
delivered to assembly
|Jun 20, 2012||ordered to third reading cal.1450|
|Jun 18, 2012||referred to rules|
senate Bill S7778
Archive: Last Bill Status - Passed Senate
- In Committee
- On Floor Calendar
- Passed Senate
- Passed Assembly
- Delivered to Governor
- Signed/Vetoed by Governor
S7778 - Details
- Current Committee:
- Law Section:
- Public Health Law
- Laws Affected:
- Add Art 2 Title 6 §266, Pub Health L
S7778 - Summary
Relates to creating the 21st century workgroup for disease elimination and reduction; directs the study of the severity, frequency of occurrence, likelihood of recurrence, existing animal vaccines and potential human vaccines for tuberculosis, eastern equine encephalitis virus, Lyme disease, human immunodeficiency virus, and others as determined by the commissioner; requires report.
S7778 - Bill Text download pdf
S T A T E O F N E W Y O R K ________________________________________________________________________ 7778 I N S E N A T E June 18, 2012 ___________ Introduced by Sens. RITCHIE, HANNON -- read twice and ordered printed, and when printed to be committed to the Committee on Rules AN ACT to amend the public health law, in relation to creating the 21st century workgroup for disease elimination and reduction THE PEOPLE OF THE STATE OF NEW YORK, REPRESENTED IN SENATE AND ASSEM- BLY, DO ENACT AS FOLLOWS: Section 1. Article 2 of the public health law is amended by adding a new title 6 to read as follows: TITLE 6 THE 21ST CENTURY WORKGROUP FOR DISEASE ELIMINATION AND REDUCTION SECTION 266. THE 21ST CENTURY WORKGROUP FOR DISEASE ELIMINATION AND REDUCTION. S 266. THE 21ST CENTURY WORKGROUP FOR DISEASE ELIMINATION AND REDUCTION. THE 21ST CENTURY WORKGROUP FOR DISEASE ELIMINATION AND REDUCTION IS HEREBY CREATED WITHIN THE DEPARTMENT. THE WORKGROUP SHALL: 1. BE COMPRISED OF EXPERTS WITHIN THE DEPARTMENT'S BUREAU OF IMMUNIZA- TION, EXPERTS ON THE IMMUNIZATION ADVISORY COUNCIL AND OTHER EXPERTS THE COMMISSIONER DEEMS APPROPRIATE, CHARGED WITH THE MISSION OF REVIEWING EXISTING VACCINES, THE STATUS OF INTERNATIONAL RESEARCH AND DEVELOPMENT FOR VACCINES LIKELY TO BE CANDIDATES FOR THE PHARMACEUTICAL MARKETPLACE, AND TO REVIEW THE STATUS OF HEALTH THREATS WHICH COULD BE ADDRESSED BY THE DEVELOPMENT OF VACCINES; 2. STUDY THE SEVERITY, FREQUENCY OF OCCURRENCE, LIKELIHOOD OF RECUR- RENCE, EXISTING ANIMAL VACCINES AND POTENTIAL HUMAN VACCINES FOR TUBER- CULOSIS, EASTERN EQUINE ENCEPHALITIS VIRUS, LYME DISEASE, HUMAN IMMUNO- DEFICIENCY VIRUS, AND ANY OTHER DISEASE OR VIRUS THE COMMISSIONER DEEMS APPROPRIATE; 3. CONSULT WITH NATIONAL VACCINE AND IMMUNIZATION POLICY MAKING ORGAN- IZATIONS, INCLUDING BUT NOT LIMITED TO, THE ADVISORY COMMITTEE ON IMMUN- IZATION PRACTICES UNDER THE CENTERS FOR DISEASE CONTROL AND PREVENTION, THE NATIONAL INSTITUTE OF HEALTH AND THE NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES; 4. APPLY FOR GRANTS, ACCEPT GIFTS FROM PRIVATE AND PUBLIC SOURCES FOR PURPOSES SET FORTH HEREIN; AND EXPLANATION--Matter in ITALICS (underscored) is new; matter in brackets [ ] is old law to be omitted.
Open Legislation comments facilitate discussion of New York State legislation. All comments are subject to moderation. Comments deemed off-topic, commercial, campaign-related, self-promotional; or that contain profanity or hate speech; or that link to sites outside of the nysenate.gov domain are not permitted, and will not be published. Comment moderation is generally performed Monday through Friday.
By contributing or voting you agree to the Terms of Participation and verify you are over 13.